View in EDS

Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.

Saved in:
Bibliographic Details
Title: Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.
Authors: Xin L; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Mahadik R; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Prorok M; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Rodriguez MS; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Chan KQ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Tolbert T; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Li Y; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Siahaan TJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.
Source: Antibody therapeutics [Antib Ther] 2026 Feb 24; Vol. 9 (3), pp. 215-229. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 101730822 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-4236 (Electronic) Linking ISSN: 25164236 NLM ISO Abbreviation: Antib Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2516-4236
DOI:10.1093/abt/tbag005